Rituximab EfFicacy IN MyasthEnia Gravis (REFINE) | stella

Learn Data For Researchers Find trials matched to me

Learn Data For Researchers Find trials matched to me →

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Privacy ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Rituximab EfFicacy IN MyasthEnia Gravis (REFINE) | stella

Back to Myasthenia Gravis, Generalized trials

Recruiting

Plain-English translation of NCT05868837 on ClinicalTrials.gov ↗ · Source last updated August 2025 · How we translate trials

Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.

Trial locations(1 site)

Italy

Policlinico A. Gemelli IRCCS, Roma

Key details

Phase

Large-scale testing

Sponsor

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Enrollment target

~40 participants

Started

February 2022

Primary completion

July 2025

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

18 Years and older

View full record on ClinicalTrials.gov

Last updated on clinicaltrials.gov in August 2025.

Contact the research team directly

Reach out to the team running this trial. Response times vary — some teams are faster than others.

Central contact

Raffaele Iorio

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.